Literature DB >> 25323048

Two-step transplantation for primary hyperoxaluria: a winning strategy to prevent progression of systemic oxalosis in early onset renal insufficiency cases.

Kengo Sasaki1, Seisuke Sakamoto, Hajime Uchida, Takanobu Shigeta, Masatoshi Matsunami, Hiroyuki Kanazawa, Akinari Fukuda, Atsuko Nakazawa, Mai Sato, Shuichi Ito, Reiko Horikawa, Tadashi Yokoi, Noriyuki Azuma, Mureo Kasahara.   

Abstract

Several transplant strategies for PH1 have been proposed, and LT is performed to correct the metabolic defects. The patients with PH1 often suffer from ESRD and require simultaneous LKT, which leads to a long wait due to the shortage of suitable organ donors. Five patients with PH1 underwent LDLT at our institute. Three of the five patients were under dialysis before LDLT, while the other two patients were categorized as CKD stage 3. An isolated LDLT was successfully performed in all but our first case, who had complicated postoperative courses and consequently died due to sepsis after retransplantation. The renal function of the patients with CKD stage 3 was preserved after LDLT. On the other hand, our second case with ESRD underwent successful LDKT six months after LDLT, and our infant case is waiting for the subsequent KT without any post-LDLT complications after the early establishment of PD. In conclusion, a two-step transplant strategy may be needed as a life-saving option for patients with PH1 and may be possible even in small infants with systemic oxalosis. While waiting for a subsequent KT, an early resumption of PD should be considered from the perspective of the long-term requirement of RRT.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  infantile oxalosis; living donor liver transplantation; primary hyperoxaluria type 1

Mesh:

Year:  2014        PMID: 25323048     DOI: 10.1111/petr.12376

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  5 in total

Review 1.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

2.  Outcomes of liver-kidney transplantation in patients with primary hyperoxaluria: an analysis of the scientific registry of transplant recipients database.

Authors:  Jie Xiang; Zheng Chen; Fangshen Xu; Shengmin Mei; Zhiwei Li; Jie Zhou; Yinlei Dong; Yangjun Gu; Zhichao Huang; Zhenhua Hu
Journal:  BMC Gastroenterol       Date:  2020-07-03       Impact factor: 3.067

3.  Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis.

Authors:  Lars Pape; Thurid Ahlenstiel-Grunow; Johannes Birtel; Tim U Krohne; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2020-02-27       Impact factor: 3.714

4.  Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry.

Authors:  Elisabeth L Metry; Sander F Garrelfs; Hessel Peters-Sengers; Sally-Anne Hulton; Cecile Acquaviva; Justine Bacchetta; Bodo B Beck; Laure Collard; Georges Deschênes; Casper Franssen; Markus J Kemper; Graham W Lipkin; Giorgia Mandrile; Nilufar Mohebbi; Shabbir H Moochhala; Michiel J S Oosterveld; Larisa Prikhodina; Bernd Hoppe; Pierre Cochat; Jaap W Groothoff
Journal:  Kidney Int Rep       Date:  2021-11-26

5.  Transplantation outcomes in patients with primary hyperoxaluria: a systematic review.

Authors:  Elisabeth L Metry; Liza M M van Dijk; Hessel Peters-Sengers; Michiel J S Oosterveld; Jaap W Groothoff; Rutger J Ploeg; Vianda S Stel; Sander F Garrelfs
Journal:  Pediatr Nephrol       Date:  2021-04-08       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.